Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01452490 · ClinicalTrials.gov registry record · NA
Diode Laser Treatment of Onychomycosis
A NA study of Onychomycosis, sponsored by ConBio, a Cynosure Company.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT01452490 is a NA study of Onychomycosis that has completed, run by ConBio, a Cynosure Company. The registered enrollment target is 50 participants, below the 90-participant average among 11 other Onychomycosis trials with a reported enrollment target (44% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01452490, a NA study of Onychomycosis, has completed, sponsored by ConBio, a Cynosure Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate the V-Raser diode laser system with investigational Nail Fungus Handpiece in the treatment of onychomycosis.
Conditions Studied
Interventions
- DEVICE Diode Laser Treatment
Study Locations (2)
Connecticut
- Shoreline Foot and Ankle Center - New London
- Shoreline Foot and Ankle Center - Westbrook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01452490
The ClinicalTrials.gov registry entry for NCT01452490 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90-participant average among 11 other Onychomycosis trials with a reported enrollment target (44% lower). The listed sponsor is ConBio, a Cynosure Company, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Onychomycosis appearing as the primary indexed condition, and to 1 intervention - of which Diode Laser Treatment is the first listed.
NCT01452490 reports 2 study locations spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT01452490 about?
NCT01452490 is a clinical study titled "Diode Laser Treatment of Onychomycosis". The purpose of this study is to evaluate the V-Raser diode laser system with investigational Nail Fungus Handpiece in the treatment of onychomycosis.
What is the current status of trial NCT01452490?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2011-10. Estimated completion is 2013-08.
What conditions does trial NCT01452490 study?
This clinical trial studies the following conditions: Onychomycosis.
What interventions are being tested in trial NCT01452490?
The interventions under investigation include: Diode Laser Treatment (DEVICE).
Who is sponsoring clinical trial NCT01452490?
This trial is sponsored by ConBio, a Cynosure Company, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01452490 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Onychomycosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser
COMPLETED · NA
-
Study of the Use of Low Level Laser Light Therapy to Treat Toenail Fungus
COMPLETED · NA
-
Bioequivalency Study of Terbinafine Tablets Under Fed Conditions
COMPLETED · NA
-
Bioequivalency Study of Terbinafine Tablets Under Fasting Conditions
COMPLETED · NA
-
A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)
ACTIVE NOT RECRUITING · Phase 3
-
Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II)
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.